Asahi Intecc Co., Ltd.
Stock Price Chart
2026/09/25 10:48 UpdatedPrice Trend
2026/09/25 10:48 UpdatedPrice & Trading Details
2026/09/25 10:48 UpdatedPRICE
TRADING
Analyst Recommendations 15 analysts
Updated 2026/09/01Earnings Calendar
Updated 2026/09/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/08/14 | ¥18.85 | ¥20.46 | +8.6% |
| 2026/05/14 | ¥28.17 | ¥35.57 | +26.3% |
| 2026/02/13 | ¥24.48 | ¥30.19 | +23.3% |
| 2025/11/13 | ¥27.08 | ¥34.37 | +26.9% |
Shareholder Composition
Updated 2026/09/01Top Mutual Funds / ETFs
Updated 2026/09/01Major Holders
Updated 2026/09/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
3.0M | 0.00% | |
|
SmallCap World Fund Inc
|
2.5M | -9.79% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
2.0M | +3.00% | |
|
Goldman Sachs TRT-Goldman Sachs Intl Small Cap Insights Fd.
|
1.7M | +2.92% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
1.6M | 0.00% | |
|
iShares Trust-iShares MSCI EAFE Small-Cap ETF
|
859.5K | +0.27% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Pacer Advisors, Inc.
|
100 | +1.00% |
Dividend History 4Years Growth
Updated 2026/09/27| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥49 | +100.2% |
| 2025 | ¥24 | +18.9% |
| 2024 | ¥20 | +40.7% |
| 2023 | ¥14 | +20.8% |
| 2022 | ¥12 | - |
Financial Performance
2026/09/27 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥77,748M | ¥90,101M | ¥107,547M | ¥120,025M |
| Gross Profit | ¥51,082M | ¥58,832M | ¥69,053M | ¥81,235M |
| Operating Income | ¥15,243M | ¥18,035M | ¥22,139M | ¥30,083M |
| Pretax Income | ¥15,871M | ¥18,051M | ¥22,015M | ¥18,869M |
| Net Income | ¥10,857M | ¥13,106M | ¥15,808M | ¥12,737M |
| EPS | ¥40.00 | ¥48.25 | ¥58.20 | ¥46.92 |
| Operating Margin | 19.61% | 20.02% | 20.59% | 25.06% |
| Balance Sheet | ||||
| Total Assets | ¥155,127M | ¥172,644M | ¥191,614M | ¥193,187M |
| Total Equity | ¥119,457M | ¥132,311M | ¥151,214M | ¥150,555M |
| Total Liabilities | ¥35,670M | ¥40,333M | ¥40,400M | ¥42,632M |
| Cash | ¥32,321M | ¥34,884M | ¥35,658M | ¥54,200M |
| Interest-bearing Debt | ¥12,179M | ¥14,253M | ¥8,204M | ¥11,098M |
| Equity Ratio | 77.01% | 76.64% | 78.92% | 77.93% |
| D/E Ratio | 0.10 | 0.11 | 0.05 | 0.07 |
| Cash Flow | ||||
| Operating CF | ¥17,302M | ¥19,138M | ¥34,708M | ¥40,543M |
| Investing CF | -¥18,703M | -¥15,135M | -¥21,222M | -¥13,434M |
| Financing CF | ¥11,368M | -¥2,342M | -¥13,878M | -¥8,107M |
| Free CF | ¥8,742M | ¥6,425M | ¥24,164M | ¥31,965M |
| Efficiency | ||||
| ROE | 9.09% | 9.91% | 10.45% | 8.46% |
| ROA | 7.00% | 7.59% | 8.25% | 6.59% |
Latest IR Information
-
【Asahi Intecc】Executive Change | Appointment Effective July 1, 2026
Asahi Intecc has resolved to add Mr. Masahiko Miyata as Chairman of the Board of Directors, effective July 1, 2026. Mr. Miyata will leverage his extensive management experience and network within the medical device industry to support sustainable growth and...
Read more -
Regarding the Conclusion of an Exclusive Sales Agreement in the Japanese Market for Embolic Agents
Asahi Intecc Co., Ltd. concluded an exclusive sales agreement in Japan for the embolic agent "Nexsphere-F™" from Korea's NEXTBIOMEDICAL on April 9, 2026. The contract period is five years following insurance listing, with no impact on consolidated results for the...
Read more -
Notice Regarding the Publication of Asahi Intecc Group's “Integrated Report 2025”
Asahi Intecc has published the “Integrated Report 2025,” disclosing initiatives to enhance corporate value including ESG, centered on the new medium-term management plan.
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥4,431
Rating Score: 1.64 (Based on 15 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, China, and internationally. The company operates through the Medical and Device segments. It provides percutaneous coronary intervention (PCI) guide wires, guiding catheters, balloon catheters, and penetration catheters for cardiology; peripheral guide wires, IVR guide wires, micro catheters, and cerebrovascular system guide wires for peripheral vascular, abdominal vascular, and cerebrovascular systems; and catheters for angiography. The company also offers OEM ODM service services for medical devices; and medical and industrial components, such as wire rope, coils, coatings, tubes, terminal processing products, synchronous round belt, and flexible shaft. In addition, it develops, manufactures, and sells ultra-fine stainless steel wire ropes. The company was formerly known as Asahi Mini Rope Sales Co., Ltd. and changed its name to Asahi Intecc Co., Ltd. in July 1988. Asahi Intecc Co., Ltd. was incorporated in 1976 and is headquartered in Seto, Japan.
